Literature DB >> 6811607

Production of anti-basement membrane-zone antibody by peripheral blood leukocytes of pemphigoid patients.

A R Ahmed, R H Stevens, A Saxon.   

Abstract

Peripheral blood leukocytes (PBL) from patients with bullous pemphigoid stimulated by pokeweed mitogen (PWM) produce an anti-basement membrane-zone(BMZ) antibody. the antibody produced in vitro was biosynthetically radiolabeled, and its binding to the BMZ was histologically demonstrated by autoradiography. The IgG nature of the antibody was evidence by the fact that it was absorbed by rabbit anti-human IgG antiserum immunoabsorbents. The peak antibody production in vitro occurred after 6 days of culture. Antibody produced in vitro did not bind to the BMZ of human skin, but it did bind to the BMZ of the monkey esophagus. Normal human volunteers and control patients did not produce such an antibody. In other experiments the effects of adding serum containing anti-BMZ antibody to the synthesis of Ig by cells of patients and normal subjects were studied. Although serum from patients with bullous pemphigoid stimulated Ig production with either normal or BP-patient PBL, the difference was not statistically significant. The availability of the assay system allows for studying the immunoregulatory mechanism of autoantibody production in bullous pemphigoid.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811607     DOI: 10.1007/bf00915220

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  34 in total

1.  Bullous pemphigoid and dermatitis herpetiformis. Histopathologic differentiation of bullous pemphigoid and dermatitis herpetiformis.

Authors:  A M Eng; B Moncada
Journal:  Arch Dermatol       Date:  1974-07

2.  Studies of the antibodies in pemphigoid and pemphigus.

Authors:  W M Sams; P H Schur
Journal:  J Lab Clin Med       Date:  1973-08

3.  Bullous pemphigoid: elution of in vivo-fixed antibody.

Authors:  M Landry; W M Sams; R E Jordon
Journal:  J Invest Dermatol       Date:  1973-12       Impact factor: 8.551

4.  Basement zone antibodies in bullous pemphigoid.

Authors:  R E Jordon; E H Beutner; E Witebsky; G Blumental; W L Hale; W F Lever
Journal:  JAMA       Date:  1967-05-29       Impact factor: 56.272

5.  The formation of immunoglobulins by human tissues in vitro. IV. Circulating lymphocytes in normal and pathological conditions.

Authors:  R van Furth; H R Schuit; W Hijmans
Journal:  Immunology       Date:  1966-07       Impact factor: 7.397

6.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

7.  Ultrastructural localization of in vivo bound immunoglobulins in bullous pemphigoid--a preliminary report.

Authors:  G Schaumburg-Lever; A Rule; R Schmidt-Ullrich; W F Lever
Journal:  J Invest Dermatol       Date:  1975-01       Impact factor: 8.551

8.  Identification of two serum components regulating the expression of T-lymphocyte function in childhood myasthenia gravis.

Authors:  A Shore; S Limatibul; H M Dosch; E W Gelfand
Journal:  N Engl J Med       Date:  1979-09-20       Impact factor: 91.245

9.  Comparison of different epithelial substrates useful for indirect immunofluorescence testing of sera from patients with active pemphigus.

Authors:  K P Judd; H Mescon
Journal:  J Invest Dermatol       Date:  1979-06       Impact factor: 8.551

10.  Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

View more
  1 in total

1.  Production of pemphigus antibody in vitro and analysis of T-cell subsets.

Authors:  A R Ahmed; R I Murahata; R W Schroff; R M Stevens; A S Saxon
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.